Clinical Trial Update: An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB [Phase 1, Phase 2]

View source ↗

Summary

An open-label Phase 1/2 study of JR-446 for the treatment of Mucopolysaccharidosis type IIIB is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type Iiib

Drugs mentioned

• JR-446

Snippet

Sponsor: JCR Pharmaceuticals Co., Ltd. | Conditions: Mucopolysaccharidosis III-B | Phase 1, Phase 2 | Status: RECRUITING